Related Experiment Videos
Diagnosis of CNS leukemia
The American Journal of Pediatric Hematology/Oncology
|January 1, 1979
Summary
Cytocentrifuge analysis effectively differentiates malignant from nonmalignant cells in cerebrospinal fluid (CSF) of leukemic patients. Complete absence of blasts is crucial for defining remission in meningeal leukemia cases.
Area of Science:
- Hematology
- Oncology
- Neurology
Background:
- Distinguishing malignant from nonmalignant cells in cerebrospinal fluid (CSF) is critical for managing leukemic patients, especially those with pleocytosis.
- Defining remission in cases of meningeal leukemia requires precise diagnostic methods.
Observation:
- The cytocentrifuge is a reliable technique for analyzing mononuclear elements in CSF.
- Analysis of CSF in patients with a history of central nervous system (CNS) leukemia presents unique diagnostic challenges.
Findings:
- Cytocentrifuge analysis accurately distinguishes malignant from nonmalignant CSF mononuclear elements in leukemic patients with pleocytosis.
- The absence of all blast cells in CSF is a key indicator for defining remission in patients with prior meningeal leukemia.
- Rarely identified blasts in CSF via cytocentrifuge in patients with a history of CNS leukemia necessitate comprehensive clinical and laboratory evaluation.
Implications:
- This study reinforces the importance of cytocentrifuge analysis in the diagnosis and monitoring of leukemia affecting the CNS.
- Establishing clear criteria for remission is vital for effective patient management and treatment planning.
- Clinical context is essential when interpreting cytocentrifuge findings, particularly in complex cases of CNS leukemia.